glp-1 in heart failure Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation Patients With With Reduced Ejection Fraction and Implantable Cardiac Devices Pharmacological treatment for patients with
Description
GPR40 is primarily expressed by the pancreatic -cells, where it plays a pivotal role in FFA-mediated insulin secretion (249) but also in -cells (250), CCK (251), and GLP-1 (248, 252, 253)
Zepbound will be added to its formulary starting October 1
Incidence and Prevalence of Thyroid Dysfunction in Type 1 Diabetes
The effective date for most plan changes landed on January 1, 2026
